SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Checkpoint Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines

Pomerantz LLP announces that a class action lawsuit has been filed against Checkpoint Therapeutics, Inc. ("Checkpoint" or the "Company") and certain officers. The class action, filed in the United States District Court for the Southern District of...

Related Keywords

Tel Aviv ,Israel ,New York ,United States ,London ,City Of ,United Kingdom ,Chicago ,Illinois ,Paris ,France General ,France ,Abrahaml Pomerantz ,Danielle Peyton ,Los Angeles ,Checkpoint Therapeutics Inc ,United States District Court ,Securities Exchange ,Investment In Checkpoint Therapeutics Inc ,Drug Administration ,Pomerantz Law Firm Reminds Shareholders ,Checkpoint Therapeutics ,Class Action Lawsuit ,Upcoming Deadlines ,Southern District ,Securities Exchange Act ,Class Period ,Lead Plaintiff ,Biologics License Application ,